1) trioxifene
曲沃昔芬
2) tamoxifen
[英][tə'mɔksifen] [美][tə'mɑksəfɛn]
他莫昔芬
1.
Tamoxifen combined with cisplatin suppress the proliferation of human ovarian cancer cell line HO-8910 in vitro;
他莫昔芬联合顺铂对人卵巢癌细胞HO-8910增殖抑制作用的研究
2.
Pharmacokinetics and bioequivalence of citric acid tamoxifen dispersible tablet in healthy volunteers;
枸橼酸他莫昔芬分散片在健康人体的药动学和生物等效性研究
3.
Changes in the Sonographic Appearance of the Uterus for Different Scheme of Tamoxifen Therapy after Climacteric;
绝经后不同方案他莫昔芬治疗对子宫内膜超声形态的影响
3) Raloxifene
雷洛昔芬
1.
Determination of Raloxifene by Resonance Rayleigh Scattering Method with Trypan Red;
测定新药雷洛昔芬的曲利本红共振瑞利散射法
2.
RminationUV Spectrophotometric Method for the Dete of Raloxifene with Evans Blue;
紫外分光光度法测定药物雷洛昔芬
3.
The effect of raloxifene on blood lipid in ovariectomized rats;
雷洛昔芬对去卵巢大鼠血脂的影响
4) bazedoxifene
苯卓昔芬
1.
Effect of bazedoxifene on biochemical markers of bone metabolism and serum lipids in healthy Chinese postmenopausal women
苯卓昔芬对健康绝经后妇女骨代谢及血脂的影响
5) raloxifene
雷诺昔芬
1.
Effects of raloxifene on the proliferation and differentiation of bone marrow stromal cells from the osteoporosis rats;
雷诺昔芬对骨质疏松大鼠骨髓基质细胞的影响
2.
In order to reduce the cost and facilitate the steps, the reaction condition was optimized and the craft of raloxifene, hydrochloride, was researched during the synthesis of it.
本文在合成雷诺昔芬(Raloxifene)的基础上,研究了各步反应的合成条件。
6) droloxifen
屈洛昔芬
1.
Mechanism of Tetrandrine in Combination with Droloxifen to Reverse Multidrug Resistance in Leukemia;
汉防己甲素联合屈洛昔芬逆转白血病细胞多药耐药机理研究
2.
The aim of this study was to investigate the mechanism to reverse the drug resistance of leukemia cells in tetrandrine (Tet) alone or in combination with droloxifen (Drol) by using protein chips and to lay the theoretical basis for the clinical applications.
本研究的目的是应用蛋白质芯片检测汉防己甲素(Tet)单独及与屈洛昔芬(Drol)伍用对作用的白血病细胞表面的耐药蛋白,包括P糖蛋白(Pgp)、多药耐药相关蛋白(MRP1)、乳腺癌耐药蛋白(BCRP)表达的作用,为逆转剂的临床应用提供理论依据。
3.
Objective: To evaluate protein array in detection of mutidrug-resistance proteins and investigate the reversal mechanism of the Tetrandrine(Tet) and Droloxifen(Drol) .
目的:对玻片表面化学修饰进行研究,探讨蛋白质芯片在检测白血病细胞MDR蛋白表达中的价值,以及进一步研究汉防己甲素和屈洛昔芬的逆转耐药机理,为两药的临床应用提供理论依据。
补充资料:他莫昔芬
分子式:C26H29NO
分子量:暂无
CAS号:10540-29-1
性质:暂无
制备方法:暂无
用途:用于晚期郛腺癌,对卵巢癌也用效,与其他抗癌药合用效果更好。
分子量:暂无
CAS号:10540-29-1
性质:暂无
制备方法:暂无
用途:用于晚期郛腺癌,对卵巢癌也用效,与其他抗癌药合用效果更好。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条